<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: We recently demonstrated that pretreatment with the synthetic <z:chebi fb="1" ids="24261">glucocorticoid</z:chebi> <z:chebi fb="0" ids="41879">dexamethasone</z:chebi> prevents hypoxic-ischemic brain damage in neonatal rats </plain></SENT>
<SENT sid="1" pm="."><plain>Presently, we examine whether this protective effect of <z:chebi fb="0" ids="41879">dexamethasone</z:chebi> is due to an improvement in local cerebral blood flow </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Neonatal rats were treated with either vehicle or 0.1 mg/kg i.p. <z:chebi fb="0" ids="41879">dexamethasone</z:chebi> 24 hours before <z:mp ids='MP_0005039'>hypoxia</z:mp>-<z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> (right carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> +3 hours of 8% O2) </plain></SENT>
<SENT sid="3" pm="."><plain>Cerebral blood flow was measured with [<z:chebi fb="32" ids="36927">14C</z:chebi>]iodoantipyrine autoradiography after either 2 (n = 17) or 3 (n = 15) hours of <z:mp ids='MP_0005039'>hypoxia</z:mp>-<z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Additional animals (n = 20) were perfusion-fixed 3 days after <z:mp ids='MP_0005039'>hypoxia</z:mp>-<z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>The area of cerebral pathological changes was measured from <z:chebi fb="1" ids="51686">hematoxylin</z:chebi> and eosin-stained coronal sections taken at three different levels </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Pathological outcome differed between groups </plain></SENT>
<SENT sid="7" pm="."><plain>In vehicle-treated rats, sections from anterior, mid, and posterior portions of the cerebrum <z:hpo ids='HP_0000001'>all</z:hpo> had extensive infarction or <z:mp ids='MP_0000316'>cellular necrosis</z:mp> ipsilateral to the occlusion (mean areas of damage were 62.6 +/- 10%, 70.2 +/- 9%, and 54.2 +/- 8%, respectively) </plain></SENT>
<SENT sid="8" pm="."><plain>However, in <z:chebi fb="0" ids="41879">dexamethasone</z:chebi>-treated animals, brain damage in sections at corresponding levels was minimal (0%, 1.6 +/- 2%, and 1.5 +/- 1%, respectively; p &lt; 0.0002) </plain></SENT>
<SENT sid="9" pm="."><plain>In contrast to the pathological results, cerebral blood flow was equivalent in the <z:chebi fb="0" ids="41879">dexamethasone</z:chebi>- and vehicle-treated groups </plain></SENT>
<SENT sid="10" pm="."><plain>After either 2 or 3 hours of <z:mp ids='MP_0005039'>hypoxia</z:mp>, cerebral blood flow was reduced 60-80% ipsilateral to the carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> in animals treated with either vehicle or <z:chebi fb="0" ids="41879">dexamethasone</z:chebi> </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: Despite ischemic levels of cerebral blood flow, pretreatment with <z:chebi fb="0" ids="41879">dexamethasone</z:chebi> prevents cerebral damage in neonatal rats </plain></SENT>
<SENT sid="12" pm="."><plain>Instead of improving local cerebral perfusion, <z:chebi fb="0" ids="41879">dexamethasone</z:chebi> presumably acts via peripheral or central <z:chebi fb="1" ids="24261">glucocorticoid</z:chebi> receptors to produce some alteration in the brain that decreases its susceptibility to <z:mp ids='MP_0005039'>hypoxia</z:mp>-<z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
</text></document>